相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibrinogen Supplementation and Its Indications
Oliver Grottke et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)
The use of coagulation factor concentrates for perioperative bleeding management - a global perspective
Oliver Grottke et al.
TRANSFUSION (2020)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model
Oliver Grottke et al.
ANESTHESIOLOGY (2019)
Four-factor Prothrombin Complex Concentrate for the Management of Patients Receiving Direct Oral Activated Factor X Inhibitors
Oliver Grottke et al.
ANESTHESIOLOGY (2019)
Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model
Oliver Grottke et al.
BRITISH JOURNAL OF ANAESTHESIA (2019)
Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis
Siavash Piran et al.
BLOOD ADVANCES (2019)
The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
Donat R. Spahn et al.
CRITICAL CARE (2019)
Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study
Sam Schulman et al.
THROMBOSIS AND HAEMOSTASIS (2018)
The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review
Maureane Hoffman et al.
INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE (2018)
Activated Protein C Drives the Hyperfibrinolysis of Acute Traumatic Coagulopathy
Ross A. Davenport et al.
ANESTHESIOLOGY (2017)
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
Ammar Majeed et al.
BLOOD (2017)
Who, when, and how to reverse non-vitamin K oral anticoagulants
Konstantinos N. Aronis et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Therapy with activated prothrombin complex concentrate is effective in reducing dabigatran-associated blood loss in a porcine polytrauma model
Markus Honickel et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
Jan C. Purrucker et al.
JAMA NEUROLOGY (2016)
Prothrombin Complex Concentrate Is Effective in Treating the Anticoagulant Effects of Dabigatran in a Porcine Polytrauma Model
Markus Honickel et al.
ANESTHESIOLOGY (2015)
Effective Reversal of Edoxaban-associated Bleeding with Four-factor Prothrombin Complex Concentrate in a Rabbit Model of Acute Hemorrhage
Eva Herzog et al.
ANESTHESIOLOGY (2015)
Prothrombin Complex Concentrates in Trauma and Perioperative Bleeding
Oliver Grottke et al.
ANESTHESIOLOGY (2015)
Reversal of Rivaroxaban-Induced Alterations on Hemostasis by Different Coagulation Factor Concentrates - In Vitro Studies With Steady and Circulating Human Blood -
Gines Escolar et al.
CIRCULATION JOURNAL (2015)
Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation
Oliver Grottke et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage
E. Herzog et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Tranexamic acid in trauma: how should we use it?
I. Roberts
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial
Joshua N. Goldstein et al.
LANCET (2015)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
J. Claude Hemphill et al.
STROKE (2015)
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
Agon Mekaj et al.
Therapeutics and Clinical Risk Management (2015)
Evolving use of new oral anticoagulants for treatment of venous thromboembolism
Calvin H. Yeh et al.
BLOOD (2014)
Characteristics of Intracerebral Hemorrhage During Rivaroxaban Treatment Comparison With Those During Warfarin
Joji Hagii et al.
STROKE (2014)
Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro
Elisabeth Perzborn et al.
THROMBOSIS RESEARCH (2014)
Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model
Eva Herzog et al.
THROMBOSIS RESEARCH (2014)
Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concentrate: a 7-day observational study of trauma patients
Herbert Schoechl et al.
CRITICAL CARE (2014)
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
Oliver Grottke et al.
CRITICAL CARE (2014)
In vitro assessment, using thrombin generation, of the applicability of prothrombin complex concentrate as an antidote for Rivaroxaban
J. Dinkelaar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Reversal of rivaroxaban anticoagulation by haemostatic agents in rats and primates
Elisabeth Perzborn et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Evaluation of Prothrombin Complex Concentrate and Recombinant Activated Factor VII to Reverse Rivaroxaban in a Rabbit Model
Anne Godier et al.
ANESTHESIOLOGY (2012)
Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents
Toshio Fukuda et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury
Oliver Grottke et al.
BLOOD (2011)
Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects
Elise S. Eerenberg et al.
CIRCULATION (2011)
A New Model for Blunt Liver Injuries in the Swine
O. Grottke et al.
EUROPEAN SURGICAL RESEARCH (2010)
Primary Fibrinolysis Is Integral in the Pathogenesis of the Acute Coagulopathy of Trauma
Jeffry L. Kashuk et al.
ANNALS OF SURGERY (2010)
Effects of different fibrinogen concentrations on blood losss and coagulation parameters in a pig model of coagulopathy with blunt liver injury
Oliver Grottke et al.
CRITICAL CARE (2010)
分享论文
